Regeneration Biomedical, Inc.
PrivateLast Round
Series B
Nov 10, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regeneration Biomedical, Inc. operates in Healthcare & Life Sciences and is based in Newport Beach, California. Its latest recorded funding round was a Series A round in July 2024.
Regeneration Biomedical, Inc. is a biotechnology company that develops direct-to-brain autologous stem cell therapies for the treatment of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regeneration Biomedical, Inc. Comparables
Compare Regeneration Biomedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UCB | 80% | |
| Aspen Neuroscience | 79% | |
| Oryon Cell Therapies | 79% |
For institutional investors. Book with your work email.
Regeneration Biomedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 10, 2025 | ||||
| Series A | Jul 1, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 90% MoM.
- Jul 1, 2024
Completed a Series A funding round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asSep 18, 2026
Regeneration Biomedical, Inc. receives Fast Track designation from the U.S. Food and Drug Administration as it advances its clinical program; the development designation does not constitute approval or establish safety or effectiveness.
For institutional investors. Book with your work email.
Regeneration Biomedical, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Regeneration Biomedical, Inc.'s valuation, stock price, and market status.
Is Regeneration Biomedical, Inc. a public or private company?
Regeneration Biomedical, Inc. is a private company.
What is the current stock price of Regeneration Biomedical, Inc.?
Regeneration Biomedical, Inc. is a private company, so its shares have no public market price. Caplight tracks Regeneration Biomedical, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Regeneration Biomedical, Inc. worth (valuation)?
Valuation information for Regeneration Biomedical, Inc. is not publicly available.
Can I buy Regeneration Biomedical, Inc. stock?
Regeneration Biomedical, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Regeneration Biomedical, Inc.'s last funding round?
Regeneration Biomedical, Inc.'s most recent funding round was Series B on November 10, 2025.
Who are the main investors in Regeneration Biomedical, Inc.?
Investor information for Regeneration Biomedical, Inc. is not publicly disclosed.
Will Regeneration Biomedical, Inc. IPO soon?
No public IPO plans have been announced for Regeneration Biomedical, Inc..
How can I track Regeneration Biomedical, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Regeneration Biomedical, Inc.'s shares on secondary markets.